超声引导下随机肾穿刺活检中彩色血流束预测并发症
回顾性分析2014至2018年单中心231例超声引导随机肾穿刺活检,总体并发症率18.2%,主要并发症率4.3%,自体肾高于移植肾(6%对0%,P=0.045)。自体肾中低eGFR(4期OR 9.405、5期OR 10.749)及穿刺后彩色血流束(OR 10.7)与并发症风险升高相关。
要点
- 穿刺后即刻出现彩色血流束提示任何并发症风险增加10.7倍(95%CI 4.595-24.994,P<.001)。
- 自体肾主要并发症率6%,显著高于移植肾的0%(P=0.045)。
- 自体肾中慢性肾病4期或5期患者主要并发症风险高于eGFR>60 mL/min者。
核心结论
- 超声引导随机自体肾活检中,低eGFR(<30 mL/min)及穿刺后即刻彩色血流束与主要并发症风险升高相关。
研究设计与样本
- 单中心回顾性研究,2014至2018年由放射科医师在超声科完成的随机肾活检共231例(自体肾167例、移植肾64例)。
- 记录患者年龄、性别、种族、eGFR及活检入路、针径、取材长度、穿刺次数和彩色血流束有无,结局包括轻微和主要并发症。
- 采用χ2分析及单变量/多变量逻辑回归评估变量间关联。
关键影像表现/征象
- 穿刺后即刻超声观察到彩色血流束(color flow tract)者任何并发症风险增加10.7倍(95%CI 4.595-24.994,P<.001)。
- 自体肾活检主要并发症率为6%,移植肾为0%,差异有统计学意义(P=0.045)。
诊断标准与关键数值
- 任何并发症总体发生率18.2%,主要并发症总体发生率4.3%。
- 自体肾中慢性肾病4期主要并发症OR 9.405(95%CI 1.995-44.338,P=0.0393),5期OR 10.749(95%CI 2.218-52.080,P=0.0203),对照为eGFR>60 mL/min者。
- 出现彩色血流束者任何并发症OR 10.7(95%CI 4.595-24.994,P<.001)。
临床应用与阅片要点
- 穿刺后即刻超声若见彩色血流束,提示任何并发症风险增加,应结合原文报告的OR值加以关注。
- 自体肾活检患者eGFR<30 mL/min(4期或5期)时主要并发症风险高于eGFR>60 mL/min者。
- 其他操作因素(入路、针径、取材长度、穿刺次数)与并发症无显著关联。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To determine patient and procedural risk factors for major complications in ultrasound (US)-guided random renal core biopsy.
METHODS: Random renal biopsies performed by radiologists in the US department at a single institution between 2014 and 2018 were retrospectively reviewed. The patient's age, sex, race, and estimated glomerular filtration rate (eGFR) were recorded. The biopsy approach, needle gauge, length of cores, number of throws, and presence of a color flow tract were recorded. Outcome data included minor and major complications. Associations between variables were tested with χ2 analyses and univariable/multivariable logistic regression models.
RESULTS: A total of 231 biopsies (167 native and 64 allografts) were reviewed. There was no significant difference in the sex, age, race, or eGFR between native and allograft groups. The overall rate for any complication was 18.2%, with a 4.3% rate of major complications, which was significantly greater in native compared to allograft biopsies (6% versus 0%; P = .045). A risk analysis in native biopsies only showed that major complications were significantly associated with a low eGFR such that patients with stage 4 or 5 kidney disease had higher odds of complications (odds ratio [95% confidence interval]: stage 4, 9.405 [1.995-44.338]; P = .0393; stage 5, 10.749 [2.218-52.080]; P = .0203) than patients with normal function (eGFR >60 mL/min). The presence of a color flow tract portended a 10.7 times greater risk of having any complication (95% confidence interval, 4.595-24.994; P < .001). Other procedural factors were not significantly associated with complications.
CONCLUSIONS: There is an increased risk of major complications in US-guided random native kidney biopsy in patients with a low eGFR (<30 mL/min) and a patent color flow tract in the immediate postbiopsy setting.
引用
- Gagnon MH, Lin MF, Lancia S, et al. A Color Flow Tract in Ultrasound-Guided Random Renal Core Biopsy Predicts Complications. J Ultrasound Med. 2020. PMID: 31995242. doi:10.1002/jum.15227
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。